N-Acetyl-B-D-Glucosaminidase as a Predictor of Milk Loss and Recovery Following Clinical Mastitis

Authors

  • D. J. Wilson Cornell University, Ithaca, NY 14850
  • P. C. Bartlett Michigan State University, E. Lansing, MI 48824
  • R. W. Mellenberger Michigan State University, E. Lansing, MI 48824
  • J. H. Kirk Auburn University, Auburn, AL 36849
  • E. C. Mather Michigan State University, E. Lansing, MI 48824

DOI:

https://doi.org/10.21423/aabppro19906816

Keywords:

Clinical mastitis, management improvements, nonclinical pathogens, milk production, economic value

Abstract

Clinical mastitis is becoming more important as management improvements have resulted in greater control of nonclinical pathogens (2,11). Economic losses due to clinical mastitis include decreased milk production, discarded milk, loss of animals due to culling or death, therapeutic costs, veterinary fees, and labor (1,5). Clinical mastitis cases vary greatly in lost milk production, duration of treatment, duration of clinical signs, and risk of culling from the herd. At the onset of signs, it is difficult to predict which cases will be most severe. Accurate early prognosis for mastitis has economic value. This study was conducted to assess the ability of a single milk NA Gase level (obtained at clinical onset) to predict severity of mastitis.

Downloads

Published

1990-09-13

Issue

Section

Research Summaries

Most read articles by the same author(s)

<< < 1 2